Search research articles
Contact Us
Filters
Showing results (611-620 of 699) with videos related to
Page
of 70
Sort By:
Journal of Medicinal Chemistry
|
April 10, 2015
Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition
Natalie H Theodoulou, Paul Bamborough, Andrew J Bannister, et al.
Metabolomics : Official Journal of the Metabolomic Society
|
September 17, 2013
Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI)
Lloyd W Sumner, Alexander Amberg, Dave Barrett, et al.
Journal of Medicinal Chemistry
|
August 14, 2020
Structure-Based Design of a Bromodomain and Extraterminal Domain (BET) Inhibitor Selective for the N-Terminal Bromodomains That Retains an Anti-inflammatory and Antiproliferative Phenotype
Christopher R Wellaway, Paul Bamborough, Sharon G Bernard, et al.
Analytical Chemistry
|
March 1, 2022
Exploration of Human Serum Lipoprotein Supramolecular Phospholipids Using Statistical Heterospectroscopy in <i>n</i>-Dimensions (SHY-<i>n</i>): Identification of Potential Cardiovascular Risk Biomarkers Related to SARS-CoV-2 Infection
Reika Masuda, Samantha Lodge, Luke Whiley, et al.
Neuroimage
|
October 11, 2011
Genetic influences on hippocampal volume differ as a function of testosterone level in middle-aged men
Matthew S Panizzon, Richard L Hauger, Lindon J Eaves, et al.
Journal of Medicinal Chemistry
|
July 24, 2020
The Optimization of a Novel, Weak Bromo and Extra Terminal Domain (BET) Bromodomain Fragment Ligand to a Potent and Selective Second Bromodomain (BD2) Inhibitor
Jonathan T Seal, Stephen J Atkinson, Helen Aylott, et al.
Journal of the American Chemical Society
|
February 10, 2022
Ultralarge Virtual Screening Identifies SARS-CoV-2 Main Protease Inhibitors with Broad-Spectrum Activity against Coronaviruses
Andreas Luttens, Hjalmar Gullberg, Eldar Abdurakhmanov, et al.
Journal of Proteome Research
|
May 19, 2021
Incomplete Systemic Recovery and Metabolic Phenoreversion in Post-Acute-Phase Nonhospitalized COVID-19 Patients: Implications for Assessment of Post-Acute COVID-19 Syndrome
Elaine Holmes, Julien Wist, Reika Masuda, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 3, 2007
Oxazolidinones as novel human CCR8 antagonists
Jian Jin, Yonghui Wang, Feng Wang, et al.
Toxicology and Applied Pharmacology
|
March 29, 2003
Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project
John C Lindon, Jeremy K Nicholson, Elaine Holmes, et al.
Page
of 70
Search research articles
Search
Showing results (611-620 of 699) with videos related to
Sort By:
Page
of 70
Journal of Medicinal Chemistry
|
April 10, 2015
Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition
Natalie H Theodoulou, Paul Bamborough, Andrew J Bannister, et al.
Metabolomics : Official Journal of the Metabolomic Society
|
September 17, 2013
Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI)
Lloyd W Sumner, Alexander Amberg, Dave Barrett, et al.
Journal of Medicinal Chemistry
|
August 14, 2020
Structure-Based Design of a Bromodomain and Extraterminal Domain (BET) Inhibitor Selective for the N-Terminal Bromodomains That Retains an Anti-inflammatory and Antiproliferative Phenotype
Christopher R Wellaway, Paul Bamborough, Sharon G Bernard, et al.
Analytical Chemistry
|
March 1, 2022
Exploration of Human Serum Lipoprotein Supramolecular Phospholipids Using Statistical Heterospectroscopy in <i>n</i>-Dimensions (SHY-<i>n</i>): Identification of Potential Cardiovascular Risk Biomarkers Related to SARS-CoV-2 Infection
Reika Masuda, Samantha Lodge, Luke Whiley, et al.
Neuroimage
|
October 11, 2011
Genetic influences on hippocampal volume differ as a function of testosterone level in middle-aged men
Matthew S Panizzon, Richard L Hauger, Lindon J Eaves, et al.
Journal of Medicinal Chemistry
|
July 24, 2020
The Optimization of a Novel, Weak Bromo and Extra Terminal Domain (BET) Bromodomain Fragment Ligand to a Potent and Selective Second Bromodomain (BD2) Inhibitor
Jonathan T Seal, Stephen J Atkinson, Helen Aylott, et al.
Journal of the American Chemical Society
|
February 10, 2022
Ultralarge Virtual Screening Identifies SARS-CoV-2 Main Protease Inhibitors with Broad-Spectrum Activity against Coronaviruses
Andreas Luttens, Hjalmar Gullberg, Eldar Abdurakhmanov, et al.
Journal of Proteome Research
|
May 19, 2021
Incomplete Systemic Recovery and Metabolic Phenoreversion in Post-Acute-Phase Nonhospitalized COVID-19 Patients: Implications for Assessment of Post-Acute COVID-19 Syndrome
Elaine Holmes, Julien Wist, Reika Masuda, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 3, 2007
Oxazolidinones as novel human CCR8 antagonists
Jian Jin, Yonghui Wang, Feng Wang, et al.
Toxicology and Applied Pharmacology
|
March 29, 2003
Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project
John C Lindon, Jeremy K Nicholson, Elaine Holmes, et al.
Page
of 70